Walleye Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.3K Sell
2,100
-25,500
-92% -$791K ﹤0.01% 3778
2025
Q4
$772K Buy
27,600
+15,300
+124% +$458K ﹤0.01% 2638
2025
Q3
$369K Buy
+12,300
New +$347K ﹤0.01% 2839
2023
Q4
Sell
-300
Closed -$8.4K 4893
2023
Q3
$8.4K Buy
+300
New +$8.79K ﹤0.01% 4504
2020
Q1
Sell
-1,000
Closed -$20K 870
2019
Q4
$20K Buy
+1,000
New +$19.9K ﹤0.01% 1601
2019
Q2
Sell
-8,400
Closed -$307K 1693
2019
Q1
$307K Buy
+8,400
New +$277K 0.05% 589

Other funds holding ALKS

Walleye Capital's ALKS Position: Q1 2026 in Review

Walleye Capital reduced its Alkermes (ALKS) stake by 77% in Q1 2026, selling an estimated $514K and leaving 5,029 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #3404.

Walleye Capital first reported a position in ALKS in Q1 2019 and has held it in 10 quarters since. The position peaked at $2.57M in Q2 2022. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Walleye Capital held 5,029 shares of Alkermes worth $178K as of Q1 2026.
  • Walleye Capital sold 16,568 Alkermes shares in Q1 2026, an estimated $514K.
  • Alkermes made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3404 holding.
  • Walleye Capital first reported a position in Alkermes in Q1 2019 and has held it in 10 quarters since.
  • Walleye Capital's Alkermes position peaked at $2.57M in Q2 2022.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.